Taysha Gene Therapies

Last updated: October 12, 2024

RA Session II, president, CEO and founder
RA Session II, president, CEO and founder
USA | Funding: $543M (+)

Website: https://tayshagtx.com/

Taysha Gene Therapies is a developer of treatments to eradicate severe & life-threatening monogenic diseases of the central nervous system.